Dauch Sees FY2026 Sales $10.3B-$10.7B, Includes Partial Year Contribution From Dowlais (As Of February 3 Close)

Dauch's 2026 Financial Outlook

Dauch's full year 2026 financial targets which include a partial year contribution from Dowlais (as of February 3 close) are as follows:   

• Sales in the range of $10.3 - $10.7 billion.
• Adjusted EBITDA in the range of $1.3 - 1.4 billion.
• Adjusted EBITDA includes synergy benefits of $50 - $75 million, equating to a run rate of greater than $100 million by the end of year one. 
• Equity income from our China JV (which is included in Adjusted EBITDA) in the range of $65 - $75 million.
• Adjusted free cash flow in the range of $235 - $325 million.
• Capital expenditures in the range of 4.5% to 5% of sales.
• Restructuring cash payments of $110 - $150 million.
• Synergy implementation cash payments of $100 - $125 million.

These targets are based on the following assumptions for 2026:  

• Production outlook:

• Production estimates of key programs that we support.
• No changes to USMCA and mitigation of a majority of incremental tariff costs.
• Based on preliminary estimate of impacts of IFRS to U.S. GAAP conversion for partial year contribution from Dowlais.